Erez Feige, Ph.D., M.B.A. joined VBL Therapeutics in 2006. He brings over 15 years of experience in business development, strategic planning, intellectual property and investor relations and helped VBL raise over $180 million in equity capital and non-dilutive sources. He has scientific expertise in cancer, immunology, biochemistry and molecular biology and was involved in the development of VBL's technologies and pipeline products. Dr. Feige received a doctor of philosophy degree and a master’s of business administration degree from Bar-Ilan University in Ramat Gan, Israel and completed a post-doctoral fellowship at the Dana-Farber Cancer Institute and Harvard Medical School in Boston.